METTL3‐mediated m6A modification of pri‐miR‐148a‐3p affects prostate cancer progression by regulating TXNIP

OBJECTIVE Prostate cancer (PCa) severely affects men's health worldwide. The mechanism of methyltransferase-like 3 (METTL3) in affecting PCa development by regulating miR-148a-3p expression via N6-methyladenosine (m6A) modification was investigated. METHODS METTL3, miR-148a-3p, and thioredoxin interacting protein (TXNIP) levels were determined using RT-qPCR and Western blotting. The m6A modification level of miR-148a-3p was observed by Me-RIP assay. Bioinformatics website predicted miR-148a-3p and TXNIP levels in PCa and their correlation, and the binding site between them was verified by dual-luciferase assay. The proliferation, migration, invasion, and apoptosis of PCa cells were examined by CCK-8 assay, Transwell assay, and flow cytometry. A transplanted tumor model was established in nude mice to observe the tumor growth ability, followed by determination of TXNIP levels in tumor tissues by immunohistochemistry. RESULTS METTL3 interference restrained the proliferation, migration, and invasion and promoted apoptosis of PCa cells. METTL3 up-regulated miR-148a-3p by promoting the m6A modification of pri-miR-148a-3p in PCa cells. miR-148a-3p overexpression nullified the inhibitory actions of silencing METTL3 on PCa cell growth. miR-148a-3p facilitated PCa cell growth by silencing TXNIP. METTL3 interference inhibited tumor growth by down-regulating miR-148a-3p and up-regulating TXNIP. CONCLUSION METTL3 promoted miR-148a-3p by mediating the m6A modification of pri-miR-148a-3p, thereby targeting TXNIP, interfering with METTL3 to inhibit the proliferation, migration and invasion of PCa cells, promote apoptosis, and inhibit tumor growth in nude mice.

[1]  A. Jemal,et al.  Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[2]  S. Zappavigna,et al.  A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells , 2022, International journal of molecular sciences.

[3]  A. Rouhi,et al.  miR-148a-3p and DDX6 functional link promotes survival of myeloid leukemia cells , 2022, Blood advances.

[4]  E. Rakha,et al.  The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer , 2022, Cancers.

[5]  Fumihiko Urabe,et al.  miRNAs in prostate cancer: Intercellular and extracellular communications , 2022, International journal of urology : official journal of the Japanese Urological Association.

[6]  S. Mashele,et al.  Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches , 2022, Molecules.

[7]  Mahasin Abdel Rhman,et al.  Potential therapeutic applications of microRNAs in cancer diagnosis and treatment: Sharpening a double-edged sword? , 2022, European journal of pharmacology.

[8]  Wei Wei,et al.  Paeoniflorin-6'O-benzene sulfonate suppresses fibroblast-like synoviocytes proliferation and migration in rheumatoid arthritis through regulating GRK2-Gβγ interaction. , 2022, Experimental and therapeutic medicine.

[9]  Minglong Shao,et al.  The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research , 2022, Frontiers in Pharmacology.

[10]  Y. Zhu,et al.  METTL3 promotes prostate cancer progression by regulating miR‐182 maturation in m6A‐dependent manner , 2022, Andrologia.

[11]  Alhaji Osman Smith,et al.  The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors , 2022, Frontiers in Immunology.

[12]  Huan Xu,et al.  METTL3-Mediated m6A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling , 2022, Cell transplantation.

[13]  L. Zuo,et al.  Function of N6-Methyladenosine Modification in Tumors , 2021, Journal of oncology.

[14]  E. Konac,et al.  miR-148a, miR-152 and miR-200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression , 2021, Oncology letters.

[15]  Jianquan Hou,et al.  METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d , 2021, Aging.

[16]  H. Masutani Thioredoxin-Interacting Protein in Cancer and Diabetes , 2021, Antioxidants & redox signaling.

[17]  Yabing Chen,et al.  Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells , 2021, Theranostics.

[18]  D. Ribatti,et al.  microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis , 2020, Frontiers in Oncology.

[19]  Wei Wang,et al.  Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer , 2020, Cell biology international.

[20]  Dong Li,et al.  MiR-135a-5p inhibits vascular smooth muscle cells proliferation and migration by inactivating FOXO1 and JAK2 signaling pathway. , 2020, Pathology, research and practice.

[21]  E. Li,et al.  METTL3 enhances cell adhesion through stabilizing integrin β1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma. , 2020, American journal of cancer research.

[22]  Yun Wang,et al.  METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway , 2020, Frontiers in Oncology.

[23]  Ying Luo,et al.  miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer , 2019, Journal of breast cancer.

[24]  Shao-Gang Ma,et al.  Suppression of long non‐coding RNA TNRC6C‐AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway , 2019, Cell proliferation.

[25]  Yan Li,et al.  Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia. , 2019, Molecular medicine reports.

[26]  Danyang Yu,et al.  METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition. , 2018, Gynecologic oncology.

[27]  T. Du,et al.  Long non‐coding RNA CCAT1/miR‐148a/PKCζ prevents cell migration of prostate cancer by altering macrophage polarization , 2018, The Prostate.

[28]  H. Guan,et al.  MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression. , 2018, Thyroid : official journal of the American Thyroid Association.

[29]  R. DePinho,et al.  Genetics and biology of prostate cancer , 2018, Genes & development.

[30]  J. Halgunset,et al.  Increased levels of serum miR‐148a‐3p are associated with prostate cancer , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[31]  P. Manavella,et al.  miRNA Biogenesis: A Dynamic Pathway. , 2016, Trends in plant science.

[32]  Gang Zhang,et al.  Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway , 2016, Oncotarget.

[33]  H. Abrahamse,et al.  The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. , 2016, Journal of photochemistry and photobiology. B, Biology.

[34]  D. Stewart,et al.  Customized Internal Reference Controls for Improved Assessment of Circulating MicroRNAs in Disease , 2015, PloS one.

[35]  S. Tavazoie,et al.  N6-methyladenosine marks primary microRNAs for processing , 2015, Nature.

[36]  Hailong Xie,et al.  U6 is not a suitable endogenous control for the quantification of circulating microRNAs. , 2014, Biochemical and biophysical research communications.

[37]  Y. Homma,et al.  miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression , 2010, Prostate Cancer and Prostatic Diseases.

[38]  Muneesh Tewari,et al.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). , 2010, Methods.

[39]  Ryan M. O’Connell,et al.  Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.

[40]  Shan Jiang,et al.  Silencing of DJ-1 reduces proliferation, invasion, and migration of papillary thyroid cancer cells in vitro, probably by increase of PTEN expression. , 2019, International journal of clinical and experimental pathology.

[41]  A. Jemal,et al.  Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. , 2019, European urology.